Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TGFBI Antikörper (N-Term)

TGFBI Reaktivität: Human WB, EIA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN955176
  • Target Alle TGFBI Antikörper anzeigen
    TGFBI (Transforming Growth Factor, beta-Induced, 68kDa (TGFBI))
    Bindungsspezifität
    • 10
    • 9
    • 6
    • 6
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 105-135, N-Term
    Reaktivität
    • 57
    • 22
    • 20
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Wirt
    • 50
    • 7
    • 2
    Kaninchen
    Klonalität
    • 43
    • 16
    Polyklonal
    Konjugat
    • 34
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser TGFBI Antikörper ist unkonjugiert
    Applikation
    • 44
    • 24
    • 15
    • 12
    • 11
    • 8
    • 5
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), Enzyme Immunoassay (EIA)
    Spezifität
    Thisa ntibody detects TGFBI / BIGH3 (N-term).
    Kreuzreaktivität (Details)
    Species reactivity (tested):Human
    Aufreinigung
    Protein A column followed by peptide affinity purification
    Immunogen
    KLH conjugated synthetic peptide between 105-135 amino acids from the N-terminal region of human TGFBI
    Isotyp
    Ig Fraction
    Top Product
    Discover our top product TGFBI Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.25 mg/mL
    Buffer
    PBS with 0.09 % (W/V) sodium azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store at 2 - 8 °C for up to six months or (in aliquots) at -20 °C for longer.
  • Target
    TGFBI (Transforming Growth Factor, beta-Induced, 68kDa (TGFBI))
    Andere Bezeichnung
    TGFBI / BIGH3 (TGFBI Produkte)
    Synonyme
    TGFBI antikoerper, BIGH3 antikoerper, CDB1 antikoerper, CDG2 antikoerper, CDGG1 antikoerper, CSD antikoerper, CSD1 antikoerper, CSD2 antikoerper, CSD3 antikoerper, EBMD antikoerper, LCD1 antikoerper, 68kDa antikoerper, AI181842 antikoerper, AI747162 antikoerper, Beta-ig antikoerper, big-h3 antikoerper, Big-h3 antikoerper, MP70 antikoerper, MP78 antikoerper, hm:zeh0933 antikoerper, wu:fa13f05 antikoerper, zgc:110495 antikoerper, transforming growth factor beta induced antikoerper, transforming growth factor, beta induced antikoerper, transforming growth factor, beta-induced antikoerper, TGFBI antikoerper, Tgfbi antikoerper, tgfbi antikoerper
    Hintergrund
    This gene encodes an RGD-containing protein that binds to type I, II and IV collagens. The RGD motif is found in many extracellular matrix proteins modulating cell adhesion and serves as a ligand recognition sequence for several integrins. This protein plays a role in cell-collagen interactions and may be involved in endochondrial bone formation in cartilage. The protein is induced by transforming growth factor-beta and acts to inhibit cell adhesion. Mutations in this gene are associated with multiple types of corneal dystrophy.Synonyms: Beta ig-h3, Kerato-epithelin, RGD-CAP, RGD-containing collagen-associated protein, Transforming growth factor-beta-induced protein ig-h3
    Gen-ID
    7045
    NCBI Accession
    NP_000349
Sie sind hier:
Kundenservice